Compare ATRC & HTGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | HTGC |
|---|---|---|
| Founded | 2000 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.8B | 3.0B |
| IPO Year | 2005 | 2004 |
| Metric | ATRC | HTGC |
|---|---|---|
| Price | $55.34 | $15.43 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 9 |
| Target Price | ★ $64.89 | $19.50 |
| AVG Volume (30 Days) | 703.8K | ★ 1.4M |
| Earning Date | 11-03-2026 | 10-29-2026 |
| Dividend Yield | N/A | ★ 12.03% |
| EPS Growth | ★ 74.74 | 14.91 |
| EPS | 0.27 | ★ 1.39 |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $13.42 | $9.11 |
| Revenue Next Year | $12.24 | $8.84 |
| P/E Ratio | $203.74 | ★ $11.24 |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $13.70 |
| 52 Week High | $66.02 | $19.13 |
| Indicator | ATRC | HTGC |
|---|---|---|
| Relative Strength Index (RSI) | 43.66 | 29.87 |
| Support Level | $55.16 | $15.17 |
| Resistance Level | $61.70 | $15.89 |
| Average True Range (ATR) | 3.02 | 0.30 |
| MACD | -0.78 | -0.08 |
| Stochastic Oscillator | 12.03 | 0.34 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
Hercules Capital Inc is a specialty finance company focused on providing senior secured loans to high-growth, venture capital-backed, and institutional-backed companies in a variety of technology and life sciences industries. The company's primary business objectives are to increase its net income, net investment income, and net asset value (NAV) through its investments mainly in structured debt or senior secured debt instruments of venture capital-backed and institutional-backed companies across a variety of technology-related industries at attractive yields. It finances companies belonging to computer software and hardware, networking systems, semiconductors, medical devices, bio-pharmaceutical, and other related sectors.